 |
PDBsum entry 4mlx
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.4.2.1.1
- carbonic anhydrase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
hydrogencarbonate + H+ = CO2 + H2O
|
 |
 |
 |
 |
 |
hydrogencarbonate
|
+
|
H(+)
|
=
|
CO2
|
+
|
H2O
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Cofactor:
|
 |
Zn(2+)
|
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Am Chem Soc
136:5400-5406
(2014)
|
|
PubMed id:
|
|
|
|
|
| |
|
'Unconventional' coordination chemistry by metal chelating fragments in a metalloprotein active site.
|
|
D.P.Martin,
P.G.Blachly,
A.R.Marts,
T.M.Woodruff,
C.A.de Oliveira,
J.A.McCammon,
D.L.Tierney,
S.M.Cohen.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The binding of three closely related chelators:
5-hydroxy-2-methyl-4H-pyran-4-thione (allothiomaltol, ATM),
3-hydroxy-2-methyl-4H-pyran-4-thione (thiomaltol, TM), and
3-hydroxy-4H-pyran-4-thione (thiopyromeconic acid, TPMA) to the active site of
human carbonic anhydrase II (hCAII) has been investigated. Two of these ligands
display a monodentate mode of coordination to the active site Zn(2+) ion in
hCAII that is not recapitulated in model complexes of the enzyme active site.
This unprecedented binding mode in the hCAII-thiomaltol complex has been
characterized by both X-ray crystallography and X-ray spectroscopy. In addition,
the steric restrictions of the active site force the ligands into a 'flattened'
mode of coordination compared with inorganic model complexes. This change in
geometry has been shown by density functional computations to significantly
decrease the strength of the metal-ligand binding. Collectively, these data
demonstrate that the mode of binding by small metal-binding groups can be
significantly influenced by the protein active site. Diminishing the strength of
the metal-ligand bond results in unconventional modes of metal coordination not
found in typical coordination compounds or even carefully engineered active site
models, and understanding these effects is critical to the rational design of
inhibitors that target clinically relevant metalloproteins.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |